<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01777568</url>
  </required_header>
  <id_info>
    <org_study_id>12-891</org_study_id>
    <nct_id>NCT01777568</nct_id>
  </id_info>
  <brief_title>Supplemental Oxygen in Colorectal Surgery: A Quality Improvement Project</brief_title>
  <official_title>Supplemental Oxygen and Surgical-site Infections: An Alternating Intervention Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary objective is to develop a clinical pathway for care of patients having colorectal
      surgery at the Clinic. In particular, the investigators would like to determine what
      intraoperative concentration of oxygen is optimal in our patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators therefore propose to test the primary hypothesis that supplemental oxygen
      (80% versus 30%) reduces the risk of a composite of surgical sites infection and potentially
      oxygen-related wound complications. Secondarily, the investigators will assess the
      incremental cost benefit of 80% versus 30% oxygen. As a safety measure, enough oxygen will
      always be given to maintain oxygen saturation (as determined by pulse oximetry) â‰¥95%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2012</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The designated operating-room suite alternated between using either 30% oxygen as tolerated or 80% oxygen for periods of 2 weeks. For example, the first period used 30% oxygen, the second 80% oxygen, and so on. The oxygen concentration during the initial period was randomly designated by the study statistician. But, thereafter, oxygen delivery was not randomized on a per-patient or even per-period basis.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With One or More Composite Complications</measure>
    <time_frame>Postoperative 30 days</time_frame>
    <description>A composite of complications:
surgical sites infection (organ space / deep)
Anastomotic leak
Intra-abdominal abscess
Sepsis
Wound dehiscence
Death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Superficial SSI (Surgical Site Infection)</measure>
    <time_frame>Postoperative 30 days</time_frame>
    <description>superficial SSI (Surgical Site Infection)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5749</enrollment>
  <condition>30% Oxygen Concentration During Colorectal Surgery</condition>
  <condition>80% Oxygen Concentration During Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>30% oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inspired oxygen will be maintained at 30%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>80% oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inspired oxygen will be maintained at 80%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30% oxygen</intervention_name>
    <description>Inspired oxygen will be maintained at 30%.</description>
    <arm_group_label>30% oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>80% oxygen</intervention_name>
    <description>Inspired oxygen will be maintained at 30%.</description>
    <arm_group_label>80% oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult colorectal surgical patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Kurz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveand Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>December 20, 2012</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <results_first_submitted>July 16, 2018</results_first_submitted>
  <results_first_submitted_qc>April 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 5, 2019</results_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Andrea Kurz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>30% Oxygen</title>
          <description>Inspired oxygen will be maintained at 30%.
30% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
        <group group_id="P2">
          <title>80% Oxygen</title>
          <description>Inspired oxygen will be maintained at 80%.
80% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2853"/>
                <participants group_id="P2" count="2896"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2853"/>
                <participants group_id="P2" count="2896"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>30% Oxygen</title>
          <description>Inspired oxygen will be maintained at 30%.
30% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
        <group group_id="B2">
          <title>80% Oxygen</title>
          <description>Inspired oxygen will be maintained at 80%.
80% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2853"/>
            <count group_id="B2" value="2896"/>
            <count group_id="B3" value="5749"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="17"/>
                    <measurement group_id="B2" value="52" spread="17"/>
                    <measurement group_id="B3" value="52" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1358"/>
                    <measurement group_id="B2" value="1387"/>
                    <measurement group_id="B3" value="2745"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1495"/>
                    <measurement group_id="B2" value="1509"/>
                    <measurement group_id="B3" value="3004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2558"/>
                    <measurement group_id="B2" value="2627"/>
                    <measurement group_id="B3" value="5185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Africa American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="207"/>
                    <measurement group_id="B3" value="442"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With One or More Composite Complications</title>
        <description>A composite of complications:
surgical sites infection (organ space / deep)
Anastomotic leak
Intra-abdominal abscess
Sepsis
Wound dehiscence
Death</description>
        <time_frame>Postoperative 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>30% Oxygen</title>
            <description>Inspired oxygen will be maintained at 30%.
30% oxygen: Inspired oxygen will be maintained at 30%.</description>
          </group>
          <group group_id="O2">
            <title>80% Oxygen</title>
            <description>Inspired oxygen will be maintained at 80%.
80% oxygen: Inspired oxygen will be maintained at 30%.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With One or More Composite Complications</title>
          <description>A composite of complications:
surgical sites infection (organ space / deep)
Anastomotic leak
Intra-abdominal abscess
Sepsis
Wound dehiscence
Death</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2853"/>
                <count group_id="O2" value="2896"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="314"/>
                    <measurement group_id="O2" value="314"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>GEE model</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.14</ci_upper_limit>
            <estimate_desc>Relative Risk: 80% (numerator) vs. 30% (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Superficial SSI (Surgical Site Infection)</title>
        <description>superficial SSI (Surgical Site Infection)</description>
        <time_frame>Postoperative 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>30% Oxygen</title>
            <description>Inspired oxygen will be maintained at 30%.
30% oxygen: Inspired oxygen will be maintained at 30%.</description>
          </group>
          <group group_id="O2">
            <title>80% Oxygen</title>
            <description>Inspired oxygen will be maintained at 80%.
80% oxygen: Inspired oxygen will be maintained at 30%.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Superficial SSI (Surgical Site Infection)</title>
          <description>superficial SSI (Surgical Site Infection)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2853"/>
                <count group_id="O2" value="2896"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183"/>
                    <measurement group_id="O2" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.047</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>1.01</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30-day postoperatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>30% Oxygen</title>
          <description>Inspired oxygen will be maintained at 30%.
30% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
        <group group_id="E2">
          <title>80% Oxygen</title>
          <description>Inspired oxygen will be maintained at 80%.
80% oxygen: Inspired oxygen will be maintained at 30%.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2853"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="2896"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="314" subjects_at_risk="2853"/>
                <counts group_id="E2" subjects_affected="314" subjects_at_risk="2896"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>SSI (organ space/deep)</sub_title>
                <counts group_id="E1" events="112" subjects_affected="112" subjects_at_risk="2853"/>
                <counts group_id="E2" events="118" subjects_affected="118" subjects_at_risk="2896"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" events="36" subjects_affected="36" subjects_at_risk="2853"/>
                <counts group_id="E2" events="34" subjects_affected="34" subjects_at_risk="2896"/>
              </event>
              <event>
                <sub_title>Intra-abdominal abscess</sub_title>
                <counts group_id="E1" events="143" subjects_affected="143" subjects_at_risk="2853"/>
                <counts group_id="E2" events="133" subjects_affected="133" subjects_at_risk="2896"/>
              </event>
              <event>
                <sub_title>sepsis</sub_title>
                <counts group_id="E1" events="94" subjects_affected="94" subjects_at_risk="2853"/>
                <counts group_id="E2" events="96" subjects_affected="96" subjects_at_risk="2896"/>
              </event>
              <event>
                <sub_title>wound dehiscence</sub_title>
                <counts group_id="E1" events="43" subjects_affected="43" subjects_at_risk="2853"/>
                <counts group_id="E2" events="43" subjects_affected="43" subjects_at_risk="2896"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="183" subjects_at_risk="2853"/>
                <counts group_id="E2" subjects_affected="150" subjects_at_risk="2896"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>uperficial SSI</sub_title>
                <counts group_id="E1" events="183" subjects_affected="183" subjects_at_risk="2853"/>
                <counts group_id="E2" events="150" subjects_affected="150" subjects_at_risk="2896"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurz, M.D., Andrea</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>(216) 445-9924</phone>
      <email>KURZA@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

